Home » Topics » HIV/AIDS, BioWorld Science

HIV/AIDS, BioWorld Science
RSS

Additional AIDS gene therapy phase II trial

June 14, 1996

Rescriptor available through Canadian expanded access program

June 14, 1996

GS-840 enters phase II/III

June 14, 1996

Sankyo reports anti-HIV-1 oligodeoxyribonucleotides

June 14, 1996

Immunostimulating whole plant product undergoes clinical trials on AIDS patients

June 7, 1996

NSC-158393: Promising candidate for development as anti-AIDS drug

June 7, 1996

Unimed announces licensing agreement on its testosterone products

May 31, 1996

NSC-645793 and NSC-651016: Anti-HIV agents with potential as clinical candidates

May 31, 1996

Marketing agreement for trimetrexate glucuronate announced

May 31, 1996

European patent covering lamivudine issued

May 31, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 15, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 16, 2025.
Neutrophils put the brakes on fat loss
BioWorld Science
Fat tissue balances energy by storing lipids during times of abundance and mobilizing them when needed, yet sustained metabolic stress demands mechanisms that...
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
Peptidream reveals milestone in Alnylam collaboration
BioWorld Science
Peptidream Inc. has announced a preclinical development milestone in its collaboration with Alnylam Pharmaceuticals Inc. under their siRNA conjugate discovery...